Clinical profile of high-risk febrile neutropenia in a tertiary care hospital

Mohan V. Bhojaraja, Sushma T. Kanakalakshmi, Mukhyaprana M. Prabhu, Joseph Thomas

Research output: Contribution to journalArticle

Abstract

Background: Infection in the immunocompromised host has been a reason of concern in the clinical setting and a topic of debate for decades. In this study, the aim was to analyse the clinical profile of high-risk febrile neutropenic patients. Aims: To study the clinical profile of high risk febrile neutropenia patients with the objective of identifying the most common associated malignancy, most common associated pathogen, the source of infection, to correlate the treatment and management with that of the Infectious Diseases Society of America (IDSA) 2010 guidelines and to assess the clinical outcome. Methods: A cross-sectional time bound study was carried out and a total of 80 episodes of high-risk febrile neutropenia were recorded among patients with malignancies from September 2011 to July 2013 with each episode being taken as a new case. Results: Non-Hodgkin’s lymphoma (30 per cent) was the most common malignancy associated, commonest source of infection was due to central venous catheters, the commonest pathogens were gram negative (52 per cent) the treatment and management of each episode of high risk febrile neutropenia correlated with that of IDSA 2010 guidelines and the mortality rate was 13.75 per cent. Conclusion: Febrile neutropenia is one of the major complications and cause of mortality in patients with malignancy and hence understanding its entire spectrum can help us reduce morbidity and mortality.

Original languageEnglish
Pages (from-to)142-151
Number of pages10
JournalAustralasian Medical Journal
Volume9
Issue number6
DOIs
Publication statusPublished - 01-01-2016

Fingerprint

Febrile Neutropenia
Tertiary Healthcare
Tertiary Care Centers
Mortality
Neoplasms
Infection
Guidelines
Central Venous Catheters
Immunocompromised Host
Non-Hodgkin's Lymphoma
Communicable Diseases
Fever
Morbidity
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Bhojaraja, Mohan V. ; Kanakalakshmi, Sushma T. ; Prabhu, Mukhyaprana M. ; Thomas, Joseph. / Clinical profile of high-risk febrile neutropenia in a tertiary care hospital. In: Australasian Medical Journal. 2016 ; Vol. 9, No. 6. pp. 142-151.
@article{44acc5b91a154bc8b168b7722baa05cc,
title = "Clinical profile of high-risk febrile neutropenia in a tertiary care hospital",
abstract = "Background: Infection in the immunocompromised host has been a reason of concern in the clinical setting and a topic of debate for decades. In this study, the aim was to analyse the clinical profile of high-risk febrile neutropenic patients. Aims: To study the clinical profile of high risk febrile neutropenia patients with the objective of identifying the most common associated malignancy, most common associated pathogen, the source of infection, to correlate the treatment and management with that of the Infectious Diseases Society of America (IDSA) 2010 guidelines and to assess the clinical outcome. Methods: A cross-sectional time bound study was carried out and a total of 80 episodes of high-risk febrile neutropenia were recorded among patients with malignancies from September 2011 to July 2013 with each episode being taken as a new case. Results: Non-Hodgkin’s lymphoma (30 per cent) was the most common malignancy associated, commonest source of infection was due to central venous catheters, the commonest pathogens were gram negative (52 per cent) the treatment and management of each episode of high risk febrile neutropenia correlated with that of IDSA 2010 guidelines and the mortality rate was 13.75 per cent. Conclusion: Febrile neutropenia is one of the major complications and cause of mortality in patients with malignancy and hence understanding its entire spectrum can help us reduce morbidity and mortality.",
author = "Bhojaraja, {Mohan V.} and Kanakalakshmi, {Sushma T.} and Prabhu, {Mukhyaprana M.} and Joseph Thomas",
year = "2016",
month = "1",
day = "1",
doi = "10.4066/AMJ.2016.2613",
language = "English",
volume = "9",
pages = "142--151",
journal = "Australasian Medical Journal",
issn = "1836-1935",
publisher = "The Australasian Medical Journal Pty. Ltd.",
number = "6",

}

Clinical profile of high-risk febrile neutropenia in a tertiary care hospital. / Bhojaraja, Mohan V.; Kanakalakshmi, Sushma T.; Prabhu, Mukhyaprana M.; Thomas, Joseph.

In: Australasian Medical Journal, Vol. 9, No. 6, 01.01.2016, p. 142-151.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical profile of high-risk febrile neutropenia in a tertiary care hospital

AU - Bhojaraja, Mohan V.

AU - Kanakalakshmi, Sushma T.

AU - Prabhu, Mukhyaprana M.

AU - Thomas, Joseph

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background: Infection in the immunocompromised host has been a reason of concern in the clinical setting and a topic of debate for decades. In this study, the aim was to analyse the clinical profile of high-risk febrile neutropenic patients. Aims: To study the clinical profile of high risk febrile neutropenia patients with the objective of identifying the most common associated malignancy, most common associated pathogen, the source of infection, to correlate the treatment and management with that of the Infectious Diseases Society of America (IDSA) 2010 guidelines and to assess the clinical outcome. Methods: A cross-sectional time bound study was carried out and a total of 80 episodes of high-risk febrile neutropenia were recorded among patients with malignancies from September 2011 to July 2013 with each episode being taken as a new case. Results: Non-Hodgkin’s lymphoma (30 per cent) was the most common malignancy associated, commonest source of infection was due to central venous catheters, the commonest pathogens were gram negative (52 per cent) the treatment and management of each episode of high risk febrile neutropenia correlated with that of IDSA 2010 guidelines and the mortality rate was 13.75 per cent. Conclusion: Febrile neutropenia is one of the major complications and cause of mortality in patients with malignancy and hence understanding its entire spectrum can help us reduce morbidity and mortality.

AB - Background: Infection in the immunocompromised host has been a reason of concern in the clinical setting and a topic of debate for decades. In this study, the aim was to analyse the clinical profile of high-risk febrile neutropenic patients. Aims: To study the clinical profile of high risk febrile neutropenia patients with the objective of identifying the most common associated malignancy, most common associated pathogen, the source of infection, to correlate the treatment and management with that of the Infectious Diseases Society of America (IDSA) 2010 guidelines and to assess the clinical outcome. Methods: A cross-sectional time bound study was carried out and a total of 80 episodes of high-risk febrile neutropenia were recorded among patients with malignancies from September 2011 to July 2013 with each episode being taken as a new case. Results: Non-Hodgkin’s lymphoma (30 per cent) was the most common malignancy associated, commonest source of infection was due to central venous catheters, the commonest pathogens were gram negative (52 per cent) the treatment and management of each episode of high risk febrile neutropenia correlated with that of IDSA 2010 guidelines and the mortality rate was 13.75 per cent. Conclusion: Febrile neutropenia is one of the major complications and cause of mortality in patients with malignancy and hence understanding its entire spectrum can help us reduce morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=84977475805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977475805&partnerID=8YFLogxK

U2 - 10.4066/AMJ.2016.2613

DO - 10.4066/AMJ.2016.2613

M3 - Article

VL - 9

SP - 142

EP - 151

JO - Australasian Medical Journal

JF - Australasian Medical Journal

SN - 1836-1935

IS - 6

ER -